Nikita Vashisht

Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook

IKS Health shares surged 9.5 per cent after announcing a $557-million TruBridge acquisition. The deal, it said, will boost EPS outlook, add EHR SaaS, and unlock $575-million cross-sell potential

Emkay Global has cut ratings on OMC stocks as rising crude and windfall tax may hit margins. The brokerage sees up to 60% decline in FY27 earnings for HPCL, BPCL, IOCL

Reliance Industries is likely to post a muted Q4FY26 results, with O2C and retail headwinds offsetting steady growth in Jio. Margins may contract sharply. Here's what brokerages expect

Iran war-led energy crisis may boost shift to renewable energy sources. Kotak Institutional Equities sees growth for CGD companies but warns of valuation, margin and demand risks

Havells India share price dropped nearly 7 per cent today after the company reported mixed Q4FY26 results. Most Bbrokerages havecut target prices amid diverging growth outlook

Analysts expect Axis Bank to report muted Q4FY26 results, with higher provisions weighing on profit even as loan growth and NII may remain steady.

360One WAM shares slipped after Q4FY26 results despite steady growth. Analysts remain bullish, seeing up to 19% upside. Check the stock's outlook

Groww Q4FY26 profit jumps 122% YoY. Analysts remain bullish on growth but flag rich valuations. Check target prices, ratings, and outlook

The Sense, Nifty surged sharply on April 21 amid easing crude oil prices, broad-based buying, and short-covering ahead of weekly F&O expiry. Check key reasons why the stock market is rising today

ICICI Bank beats estimates, but HDFC Bank posts steady Q4 results. Analysts decode growth outlook for both the banks, share price targets and if should you buy the bank stocks

MF investors see zero returns but SIP inflows remain strong. Analysts say patience may be tested, even as bull market hopes build

Motilal Oswal sees 30% upside in Dixon Technologies share price despite near-term headwinds from weak smartphone demand and rising costs. The brokerage has reiterated 'Buy' with ₹14,700 target price

HDFC Life share price fell 4 per cent today, after weak Q4FY26 results. Analysts have cut earnings estimates but remain cautiously optimistic on FY27 growth outlook and margin recovery.

Mutual funds, AMCs, and market infra players could see a multi-year earnings boom as retail investing deepens. Emkay Global, Axis Capital pick best AMC, RTA stocks to buy

Firstsource Solutions shares surged over 15% on heavy volumes today amid IT rebound. Here's what's driving the rally, Q4 expectations, and analyst views on stock outlook

ICICI Bank Q4FY26 preview: Analysts expect ICICI Bank to report steady NII growth, strong loan expansion, but muted profit due to margin pressure and provisioning normalisation.

HDFC Bank Q4FY26 results preview: Analysts expect HDFC Bank's Q4 profit to rise up to 9% Y-o-Y with strong loan growth, stable margins, and steady asset quality

Jefferies has downgraded Indus Towers shares to 'Underperform', cutting target price to ₹375. The global brokerage stated renewal risks, rising capex, and pressure on earnings and valuations as risks

Sun Pharma shares fall 5 per cent amid Organon deal buzz and US tariff concerns. Tech charts show the stock has a 'bearish' outlook